ArticleJAMIA open2026
Adaptation of a fair individualized polysocial risk score for hospitalization risk prediction.
Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Objectives: We adapted the individualized polysocial risk score (iPsRS), a machine learning model originally developed for patients with type 2 diabetes, to evaluate its generalizability in predicting 1-year hospitalization risk in a disease-agnostic adult cohort, with attention to fairness and explainability. Materials and Methods: The study utilized de-identified electronic health record data from a retrospective cohort of 17 857 adult patients at the University of Florida Health. The original iPsRS framework was reimplemented using XGBoost and Logistic Regression models. These models were trained and fine-tuned using 13 individual-level social determinants of health (SDoH) predictors to predict all-cause hospitalization within 1 year. Models were fine-tuned at 5 levels (0%, 10%, 20%, 50%, and 70%) with 3 sampling strategies (none, oversampling, and undersampling). Model performance was primarily evaluated using the AUROC. Interpretability was assessed through SHapley Additive exPlanations and a causal structure learning algorithm, while fairness was analyzed by examining false negative rate disparities across age, sex, and racial/ethnic subgroups. Results: After fine-tuning, the adapted iPsRS demonstrated moderate predictive performance, achieving an AUROC of up to 0.671 with XGBoost and Normal sampling. SHapley Additive exPlanations analysis on the evaluation split showed age, food insecurity, marital status, and financial constraints emerged as consistently influential predictors. The causal structure analysis corroborated predictive findings, identifying age, race, and employment as proximal factors associated with hospitalization. Conclusion: The iPsRS was successfully adapted beyond diabetes, maintaining moderate predictive performance and meaningful risk stratification. Incorporating individual-level SDoH enables equity-aware prediction, supporting broader use of iPsRS in clinical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.